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AbstrACt
Objective To provide an overview of care in emergency 
departments (EDs) across Europe in order to interpret 
observational data and implement interventions regarding 
the management of febrile children.
Design and setting An electronic questionnaire was 
sent to the principal investigators of an ongoing study 
(PERFORM (Personalised Risk assessment in Febrile illness 
to Optimise Real-life Management), www. perform2020. 
eu) in 11 European hospitals in eight countries: Austria, 
Germany, Greece, Latvia, the Netherlands, Slovenia, Spain 
and the UK.
Outcome measures The questionnaire covered 
indicators in three domains: local ED quality (supervision, 
guideline availability, paper vs electronic health records), 
organisation of healthcare (primary care, immunisation), 
and local factors influencing or reflecting resource use 
(availability of point-of-care tests, admission rates).
results Reported admission rates ranged from 4% 
to 51%. In six settings (Athens, Graz, Ljubljana, Riga, 
Rotterdam, Santiago de Compostela), the supervising ED 
physicians were general paediatricians, in two (Liverpool, 
London) these were paediatric emergency physicians, in 
two (Nijmegen, Newcastle) supervision could take place 
by either a general paediatrician or a general emergency 
physician, and in one (München) this could be either a 
general paediatrician or a paediatric emergency physician. 
The supervising physician was present on site in all settings 
during office hours and in five out of eleven settings during 
out-of-office hours. Guidelines for fever and sepsis were 
available in all settings; however, the type of guideline 
that was used differed. Primary care was available in all 
settings during office hours and in eight during out-of-office 
hours. There were differences in routine immunisations 
as well as in additional immunisations that were offered; 
immunisation rates varied between and within countries.
Conclusion Differences in local, regional and national 
aspects of care exist in the management of febrile children 
across Europe. This variability has to be considered when 
trying to interpret differences in the use of diagnostic tools, 
antibiotics and admission rates. Any future implementation 
of interventions or diagnostic tests will need to be aware of 
this European diversity.
IntrODuCtIOn
The emergency department (ED) is the 
setting where reliable care has to be provided 
for acutely ill patients.1 Children represent a 
large part of the ED workload, with nearly 40 
visits per 100 population.2 General as well as 
paediatric visits have increased during the last 
years.2 3
Factors that contribute to this increase are 
lack of access to 24/7 primary care, lack of 
paediatric training among primary care physi-
cians4 and parents’ preferences to go directly 
to the ED.5
Fever is one of the most frequent reason for 
consultation.2 Although most febrile episodes 
are self-limiting, infection still remains a 
common cause of death in children.6 Delayed 
recognition of potential life-threatening infec-
tions may have disastrous implications,7 while 
overtreatment can be invasive and costly and 
can lead to increasing antibiotic resistance.8 
Caring for this broad spectrum of patients 
remains an ongoing challenge, and several 
studies have shown large practice pattern vari-
ation in the care for febrile children.9
The organisation of healthcare varies 
between countries as well as hospitals. For 
example, healthcare for children can be 
delivered by general practitioners, primary 
care paediatricians, and general or paediatric 
EDs.4
It has been suggested that variation in 
healthcare organisation accounts for part 
of the differences in paediatric mortality 
in Europe.4 For example, death rates from 
illnesses that rely on first access services such 
as primary care, for example, pneumonia, are 
higher in the UK than in Germany and the 
Netherlands.4
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Our aim was to provide an overview of the delivery of 
care for febrile children at European EDs, which can aid 
the interpretation of observational studies and the imple-
mentation of future interventions.
MethODs
Participating hospitals and questionnaire development
This study is embedded in the MOFICHE study (Manage-
ment and Outcome of Fever in children in Europe), 
which is part of the European Union-funded PERFORM 
project (Personalised Risk assessment in Febrile illness 
to Optimise Real-life Management) (GA:668303, www. 
perform2020. eu) (online supplemenatary appendix 
1). MOFICHE collects information regarding patient 
characteristics, resource use (diagnostic tests, antibiotic 
prescription and hospitalisation) and outcome in febrile 
children.
An electronic questionnaire (online supplementary 
appendix 2) was sent by email to the principal investigator 
of each participating centre, which were 11 European 
hospitals in eight countries: Austria, Germany, Greece, 
Latvia, the Netherlands, Slovenia, Spain and the UK. The 
questionnaire was filled in by the principal investigator in 
collaboration with the head of the (paediatric) ED or one 
of the main consultants responsible for the care of febrile 
children at the ED.
The questionnaire was based on the article by Mintegi 
et al10 on organisation of paediatric emergency care and 
was further developed by the MOFICHE research team, 
consisting of a team of experts with a background in 
paediatrics, epidemiology, paediatric emergency care, 
paediatric infectious diseases and health economics. We 
gathered information on factors influencing case mix as 
well as resource use.
We focused on local ED quality indicators, regional 
systems of care and local factors influencing resource use 
based on Medford-Davis et al1 classification of value-based 
emergency care.1
The questionnaire was created with Google Forms. 
Questions consisted of multiple-choice or multiple-op-
tion questions, yes/no questions, 5-point Likert-scale 
questions and open questions.
All analyses were descriptive and performed with SPSS 
V.21 software. We analysed the correlation between the 
different setting characteristics using Pearson correlation 
coefficient.
Patient involvement
Patients were not directly involved in the design of this 
study.
Quality of care
In the quality of care domain, we included availability and 
type of triage system, guideline availability, paediatric 
intensive care unit (PICU) admission criteria, guidelines 
on maximum time spent in the ED, supervision, and 
availability of electronic health records (EHR).
Four types of supervision were distinguished11:
 ► Direct supervision, the supervising physician is present 
on site with the junior doctor and patient.
 ► Indirect supervision (I), the supervising physician is 
within the hospital and is immediately available for 
direct supervision.
 ► Indirect supervision (II), the supervising physician is 
not present within the hospital, but is immediately 
available by telephone and available for direct supervi-
sion within 20–30 min.
 ► Oversight, the supervising physician is available for 
feedback after care is delivered.
Office hours were defined as daytime from Monday 
to Friday. Out-of-office hours were defined as evenings, 
nights, weekends and public holidays according to the 
local organisation.
Regarding EHR we asked for the electronic availability 
of history, physical examination, vital signs, diagnostic 
tests, treatment and disposition.
regional aspects of care
In the regional aspects domain, we studied the organisa-
tion of primary care. We focused on the type of clini-
cian providing primary care, out-of-office hours availa-
bility and ED self-referral rates. Information concerning 
routine immunisation was taken from the website of the 
European Centre for Disease Prevention and Control.12
We used 2016 WHO data to outline immunisation 
rates.13
resource use
In the resource use domain, we studied admission rates and 
availability of point-of-care tests (POCT). Admission rates 
were based on annual admission rates of 2016.
results
General eD characteristics
All 11 hospitals participating in the MOFICHE study 
filled in the electronic questionnaire. Nine were univer-
sity hospitals and three were large district general hospi-
tals; seven had a dedicated paediatric ED (table 1). All 
hospitals had an onsite PICU. Nine settings served mixed 
inner-city/rural populations, and in 10 settings the popu-
lation was from a mixed socioeconomic status.
Quality of care
The Manchester Triage System (MTS) was used in eight 
settings. The other settings used a local or national triage 
system.
In six settings (Athens, Graz, Ljubljana, Riga, 
Rotterdam, Santiago de Compostela), the supervising 
ED physicians responsible for febrile children were 
general paediatricians, in two (Liverpool, London) these 
were paediatric emergency physicians, and in three 
(München, Nijmegen, Newcastle) supervision could take 
place by either a general paediatrician or an (paediatric) 
emergency physician (table 1).
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During office hours, three settings used direct supervi-
sion, while eight used type I indirect supervision. During 
out-of-office hours most settings used type II indirect 
supervision. Oversight was not used in any setting.
According to the study respondents, in four settings all 
febrile children were discussed with a supervisor during 
office hours; this number was lower during out-of-office-
hours (figure 1).
We studied the availability of guidelines for common 
infections: fever, respiratory tract infections (RTI), 
urinary tract infections (UTI) and sepsis.14 All settings 
had guidelines available for fever and sepsis. Ten settings 
had guidelines available for RTI and UTI. For fever, three 
settings used the National Institute for Health and Care 
Excellence (NICE) guideline, while eight settings used a 
local or a national guideline. For sepsis, five settings used 
the NICE guideline.
Invasive ventilation and inotrope use were reasons for 
PICU admission in all settings, while non-invasive venti-
lation was a reason for PICU admission in nine out of 
eleven settings. High-flow oxygen or continuous antiepi-
leptic drugs required PICU admission in five settings and 
continuous cardiorespiratory monitoring in four (online 
supplementary appendix 3).
Six hospitals had guidelines regarding the time a child 
could stay in the ED, after which they should be admitted 
or discharged. This varied between 3 and 24 hours.
In four settings all items were available electronically, 
and in one setting all items were registered on paper; 
all other settings used a combination of paper and EHR 
(online supplementary appendix 4). Eight settings had 
patient data (eg, vital signs) available electronically, while 
10 had diagnostic tests available electronically.
regional systems of care
In six settings, primary care was provided by general prac-
titioners, while in two settings this was offered by primary 
care paediatricians. In the other settings, primary care 
could be delivered by either type of physician. Primary 
care was available during out-of-office hours in eight 
settings. Overall, self-referral rate was high (table 1).
Immunisation to diphtheria, tetanus and acellular 
pertussis vaccine/inactivated polio vaccine/measles, 
mumps, rubella vaccine; Haemophilus influenzae type b 
vaccine; and pneumococcal conjugate vaccine (PCV) was 
part of routine care in all areas.
Meningococcal immunisation was part of routine care 
in six countries. Subtypes of PCV and meningococcal 
serotype vaccines in use differed. Other routine immu-
nisations that varied are outlined in table 2. In some 
regions, additional immunisation was offered to specific 
groups, such as influenza in children with comorbidity or 
BCG to high-risk infants.12 In Slovenia and Latvia several 
immunisations are mandatory (table 2).
Figure 2 shows the 2016 WHO immunisation data in 
the participating countries.13 Overall, immunisation 
rates are estimated to be over 90%–95%; however, in 
several countries regional data show large differences in 
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Figure 1 Supervision type and frequency: office hours versus out-of-office hours. Direct supervision: the supervising 
physician is physically present on site with the resident and patient. Indirect supervision (I): with direct supervision immediately 
available—the supervising physician is physically present within the hospital and is immediately available to provide direct 
supervision. Indirect supervision (II): with direct supervision available—the supervising physician is not physically present within 
the hospital or other sites of patient care, but is immediately available by means of telephonic and/or electronic modalities, 
and is available to provide direct supervision in person within 20–30 min at all times. Oversight: the supervising physician is 
available to provide review of procedures/encounters with feedback provided after care is delivered.
Table 2 Routine immunisation in the eight participating countries12
DTaP/IPV/MMR/Hib PCV Men Hep-A Hep-B RV Varicella Influenza BCG TBE
Austria + +10 +ACWY − + + − − − −
Germany + +13 +C − + + + − − −
Greece + +13 +C, ACWY + + + + − − −
Latvia ++ ++10 − − ++ ++ ++ + ++ +−
The Netherlands + +10 +C − + − − − − −
Slovenia ++ +10 − − ++ − − − − −
Spain + +13 +C − + − + − − −
UK + +13 +B, C, ACWY − + + − + +− −
+Routine immunisation (all children).
+−Specific regions only.
++Mandatory immunisation.
−Not part of the routine immunisation programme.
DTaP, diphtheria, tetanus and acellular pertussis vaccine; Hep-A, hepatitis A vaccine; Hep-B, hepatitis B vaccine; Hib, Haemophilus 
influenzae type b vaccine; IPV, inactivated polio vaccine; Men, meningococcal vaccine; MMR, measles, mumps, rubella vaccine; PCV, 
pneumococcal conjugate vaccine; RV, rotavirus vaccine; TBE, tick-borne encephalitis vaccine.
immunisation rates. Actual immunisation rates can be 
lower in specific regions, specific age groups, for specific 
immunisations and for booster immunisations15; there-
fore, the shown WHO data might be an overestimation 
of actual immunisation rates.
resource use
Paediatric admission rates ranged from 4% to 51% 
(table 1).
Glucose POCT was available in all settings. Blood gas 
and urinalysis were available as a POCT in nine settings 
and C reactive protein (CRP) POCT in six. Nasopha-
ryngeal aspirate tests were available in six settings and a 
streptococcal antigen test in five.
Correlations between different setting characteristics
We found strong correlations between self-referral rates 
and admission rates (r=−0.89, p<0.000), and between 
annual visits and how often febrile children were discussed 
with a senior doctor during office hours (r=−0.70, p<0.05) 
or during out-of-office hours (r=−0.82, p<0.05). We 
found moderate correlations between ED type and how 
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Figure 2 Immunisation rates.13 Slovenia PCV rate (50%) not included in the graphic. PCV immunisation rate not available 
for Austria and Spain. DTaP: percentage of surviving infants who received the third dose of diphtheria and tetanus toxoid with 
pertussis-containing vaccine. MCV: percentage of surviving infants who received the first dose of measles-containing vaccine. 
In countries where the national schedule recommends the first dose of MCV at 12 months or later based on the epidemiology 
of disease in the country, coverage estimates reflect the percentage of children who received the first dose of MCV as 
recommended. Hib: percentage of surviving infants who received the third dose of Hib-containing vaccine. PCV: percentage of 
surviving infants who received the third dose of PCV. In countries where the national schedule recommends two doses during 
infancy and a booster dose at 12 months or later based on the epidemiology of disease in the country, coverage estimates may 
reflect the percentage of surviving infants who received two doses of PCV prior to the first birthday. DTaP, diphtheria, tetanus 
and acellular pertussis vaccine; Hib, Haemophilus influenzae type b vaccine; PCV, pneumococcal conjugate vaccine. MCV, 
measles-containing vaccine.
Table 3 Factors that can potentially influence resource use, based on previous literature
Diagnostic tests Antibiotic prescription rates Admission rates
Triage ± − ±
Supervision and physician specialty ± + +
Guideline implementation + + +
Electronic health records + − −
Criteria for paediatric intensive care unit 
admission
− − +
Time spent in the emergency department − − +
Primary care and pre-hospital services + + +
Immunisation + + +
Point-of-care tests + +* +
+Possible influence.
±Influence not clear.
−No influence expected.
*In adults.
often febrile children were discussed with a senior doctor 
during out-of-office hours (r=0.63, p<0.05). We did not 
find any correlation between hospital type and admission 
rates or hospital type and how often febrile children were 
discussed with a senior doctor.
DIsCussIOn
We found several differences between the participating 
EDs regarding the care for febrile children in all three 
domains: quality indicators, regional aspects of care and 
resource use.
Based on previous literature, we will discuss which of 
these factors are likely to influence outcome measures 
such as resource use (table 3).
Although the discussed domains are based on a study 
looking into the US healthcare systems, we believe these 
domains are similarly relevant for European healthcare 
systems.4 10
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Factors influencing resource use directly
We found variability in physician specialty and super-
vision; both have been previously found to influence 
resource use.16 For example, supervised ED visits—as 
opposed to consultant alone—have been linked to higher 
resource use and longer ED stay.17
In our study we asked whether guidelines were avail-
able but did not assess actual use or adherence. Guide-
line adherence can improve the quality of care18 and has 
been shown to reduce resource use and lead to more 
appropriate antibiotic use without adversely affecting 
outcomes.19 However, despite guideline availability, there 
is considerable practice pattern variation, as guideline 
availability does not automatically lead to adherence.19
In around half of the EDs, a CRP POCT was available. 
POCT provides results quickly and therefore can reduce 
time to treatment initiation and ED length of stay.20 
CRP has shown to be of value in ruling in or out bacte-
rial infections.21 A Cochrane review concluded that the 
use of a CRP POCT could reduce antibiotic prescription 
in adults22; however, this was not confirmed in a paedi-
atric primary care population.23 In their discussion, the 
authors emphasise that performing a CRP POCT in all 
children with fever will not reduce antibiotic use, as it can 
lead to false positive values.23 Which children will benefit 
most from a CRP POCT and how this will affect resource 
use still has to be evaluated.
There were marked differences in electronic healthcare 
records (EHR) availability in our study. Use of EHR can 
increase efficiency in ordering diagnostic tests, reduce 
errors, improve overview, reduce duplicate testing and 
admissions, and improve information exchange between 
healthcare providers.24
From a researcher’s perspective, it is important to 
recognise that paper-based records can be incomplete 
and lack standardisation. Conducting research in settings 
using EHR potentially offers benefits and new opportuni-
ties,25 although aspects such as accuracy, completeness, 
standardisation, comparability and anonymity need to be 
addressed.24 25
Triage aims to prioritise patients who need imme-
diate care from those who can safely wait in order to 
improve outcomes.26 Most settings used the MTS, but 
local systems were common as well. Research has shown 
that the performance of MTS is ‘moderate to good’ in 
children; however, its performance is lower in young chil-
dren and children with comorbidities, who are at risk for 
undertriage (ie, they are assigned a lower priority level 
than they should).27 Most local systems have not been 
thoroughly validated in children.28
The impact of triage on resource use is not straight-
forward. As expected, a higher triage category is linked 
to higher resource use.29 There is some evidence that 
‘down-triaging’ of non-ill-appearing children to a lower 
category can reduce resource use without increasing 
adverse outcomes.30 On the other hand, as undertriage 
can cause treatment delay, it has been hypothesised that 
undertriage can increase resource use31 and improved 
triage can lead to more appropriate resource use.32 
However, it is possible that triage influences resource use, 
and use of different triage systems can explain practice 
pattern variation. More research is needed on this topic 
to understand this exact relationship.
Six hospitals had local guidelines on how long a child 
could stay in the ED. In the UK, it is a national target that 
95% of all ED patients should be discharged or admitted 
within 4 hours.3 Limiting ED stay can have a large impact 
on children and their families. It has been shown to 
decrease crowding and mortality and to improve patient 
satisfaction.33 However, it has also been suggested that 
the introduction of the 4-hour target has increased 
(short-duration) admission rates, but consistent data are 
lacking.3 This leads to the discussion of a possible role of 
short-stay units, as these can potentially reduce ED length 
of stay as well as admissions.34
We found marked variation in PICU admission criteria. 
This can influence general admissions as well as PICU 
admissions. PICU admissions are frequently used as an 
outcome measure for disease severity, and it is important 
to realise this can be influenced by other factors than 
disease severity alone.
Factors influencing resource use indirectly through case mix
Even though primary care was available in all settings, 
not all settings offered out-of-office primary care. 
Furthermore, the self-referral rate at the ED was high in 
many settings, suggesting that other factors than merely 
primary care availability influence self-referral. A high 
rate of self-referred patients can lead to a higher propor-
tion of non-urgent patients who can delay resources 
being given to those who need it more urgently.35
In their systematic review, Kraaijvanger et al5 identified 
several reasons for self-referral, such as patient expecta-
tions and accessibility to primary care. In some settings 
urgent primary care has been made available at the same 
site as the ED, and this has been shown to reduce self-re-
ferral rates, especially of low-urgent patients.5 In our 
study, we found a strong correlation between self-referral 
rates and admission rates.
Although there were large similarities in immunisa-
tions, there were also differences. This could explain 
some of the variation in the population and subsequent 
resource use between EDs.36 For example, the introduc-
tion of the rotavirus immunisation has led to a large 
reduction of ED visits and admissions for children with 
gastroenteritis.37
While the introduction of immunisations has led to 
a great reduction of invasive diseases,36 the presented 
data show that low immunisation rates still occur in 
Europe. Low immunisation rates can lead to increased 
susceptibility by a direct effect as well as indirect effect by 
decreasing herd immunity.38
In two recent European studies, the burden of 
life-threatening infections in children, including PICU 
admission for sepsis, was found to be largely due to 
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What is known about the subject?
 ► Fever is one of the most frequent reasons for paediatric emergency 
department consultation.
 ► Differences in outcome of paediatric infectious diseases still exist 
in Europe and have been linked to differences in organisation of 
healthcare.
What this study adds?
 ► Our study shows marked differences regarding the organisation of 
emergency care for febrile children across Europe.
 ► Differences in the organisation of healthcare can influence resource 
use such as diagnostic tests, antibiotic prescription rates and ad-
mission rates.
 ► Our study provides an overview of setting-related factors that can 
influence resource use and thus need to be considered when inter-
preting results of observational studies.
vaccine-preventable meningococcal and pneumococcal 
infections.39 40
strengths and limitations
The strengths of our study include the comprehensive 
collaboration of researchers who are part of a large Euro-
pean Union consortium, using a standardised protocol. 
To our knowledge, this is the first study comparing 
healthcare for febrile children at European EDs.
The main limitation is the proportional representa-
tion as this was a small convenience study and the survey 
was filled in by a single respondent (the principal inves-
tigator). Some of the results are based on clinicians’ 
reflection on their local practice and few on validated 
demographic or hospital data. For example, the data 
regarding socioeconomic status were based on data 
provided by the survey respondent, while data regarding 
immunisation grades were based on WHO data.
In most countries only one or two hospitals from several 
hundreds in most countries contributed to this study, and 
not all 28 European Union countries participated. There-
fore, results can reflect differences between hospitals as 
well as between countries and are not representative of 
all hospitals in the participating countries. For example, 
not all European hospitals have an onsite PICU. Further-
more, all participating hospitals were either a university 
or a large district general hospital, and results might 
therefore not be generalisable to smaller hospitals. 
However, as all participating hospitals were larger hospi-
tals, the standard of care in these hospitals is expected to 
be high, and therefore diversity might represent practice 
variability between countries. This study gives an overview 
of setting-related factors that may influence resource use; 
however, this is not exhaustive.
COnClusIOn
Our study shows differences in the emergency care for 
febrile children across Europe. Resource use such as 
diagnostic tests, antibiotic prescription and admission 
rates can be influenced by differences in the organisation 
of healthcare.
Our study provides an overview of setting-related 
factors that need to be considered when interpreting 
results of observational studies. As new interventions are 
developed, these factors need to be considered to model 
their potential impact, to accurately plan clinical trials 
and to conduct health economic analyses.
More indepth research is needed to study the factors 
described above, of which some will be covered in the 
MOFICHE study in more detail.
Studying these differences can be used as a starting 
point to improve paediatric emergency care across 
Europe.4
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